Background:
Semen analysis is the standard test for evaluating male fertility. However, it may not address all aspects
of male infertility. This review explores the role of leukocyte elastase (LE) as a possible biomarker for
male fertility by evaluating 28 corresponding studies.
Objectives:
We aimed to explore how leukocyte elastase levels in semen relate to sperm quality and pregnancy
outcomes.
Methods:
This systematic review followed PRISMA guidelines and included studies from PubMed, Medline,
EMBASE, and Scopus (March 22–25, 2024) using the keywords “Elastase,” “Sperm,” and “Semen.”
Out of 897 identified articles, 334 were screened, leading to 90 full-text reviews. We included 28 studies
reporting sperm parameters linked to LE and excluded non-English articles, reviews, and animal studies.
Data collected included study details, methods, population, LE levels, sperm characteristics, and
pregnancy outcomes. A narrative synthesis was used due to differing study designs. Quality assessment,
using the National Heart, Lung, and Blood Institute tool, rated 21 studies medium quality, 6 high, and 1
low.
Results:
Only a limited number of studies reported a correlation between leukocyte elastase levels and sperm
parameters, with no significant link to sperm concentration. Overall, we did not identify a strong
association between LE levels and pregnancy or fertilization rates.
Conclusions: While LE serves as a marker for seminal leukocyte concentration, its link to sperm quality
and fertility outcomes remains weak and inconsistent. Based on current evidence, LE does not appear to be a reliable diagnostic marker for male infertility. Future studies should focus on standardizing LE
measurement techniques and exploring its interaction with other semen parameters to clarify its role in
male fertility.